ThomasAnthonyLallasMDFACOG FACS

Obstetrics & Gynecology • New York, NY

Gynecologic Oncology

Clinical Assistant Professor

Join to view full profile

Dr. Lallas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lallas' full profile

Already have an account?

Office
877 Park Avenue
New York, NY 10075
Phone+1 212-838-0886

Fax+1 212-327-0526
Is this information wrong?

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 1996 - 1999
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Obstetrics and Gynecology, 1992 - 1996
University of Virginia School of MedicineClass of 1992

Certifications & Licensure

NY State Medical License 1994 - 2026
IA State Medical License 1996 - 2000
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACS) American College of Surgeons
Super Doctor SuperDoctors.com
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Publications & Presentations

PubMed

19 citations
Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP)
John P. Geisler, Melanie A. Hatterman-Zogg, J.A. Rathe, Thomas A. Lallas, Patricia A. Kirby, Richard E. Buller> ;Human Mutation. 2001 Oct 1
28 citations
The p53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer
Richard E. Buller, Thomas A. Lallas, Mark S. Shahin, Anil K. Sood, Melanie A. Hatterman-Zogg, Barrie Anderson, Joel I. Sorosky, Patricia A. Kirby> ;Clinical Cancer Research. 2001 Apr 1
28 citations
The Glutathione S-Transferase M1 Genotype in Ovarian Cancer
Thomas A. Lallas, Sarah K. McClain, Mark S. Shahin, Richard E. Buller> ;Cancer Epidemiology, Biomarkers & Prevention. 2000 Jun 1
16 citations
Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer.
Thomas E. Buekers, Thomas A. Lallas, Richard E. Buller> ;Gynecologic Oncology. 2000 Mar 1
6 citations
R esponse : Re: Association Between Nonrandom X-ChromosomeInactivation and BRCA1 Mutation in Germline DNA of Patients With OvarianCancer
Richard E. Buller, Anil K. Sood, Thomas A. Lallas, Thomas E. Buekers, Jeffrey S. Skilling> ;Journal of the National Cancer Institute. 1999 Sep 1
14 citations
BRCA1 mutations in familial ovarian cancer.
Thomas A. Lallas, Thomas E. Buekers, Richard E. Buller> ;Molecular Genetics and Metabolism. 1999 Aug 1
21 citations
Malignant cervical schwannoma: An unusual pelvic tumor.
Thomas A. Lallas, Philip C. Mehaffey, Donna J. Lager, Bradley J. Van Voorhis, Joel I. Sorosky> ;Gynecologic Oncology. 1999 Feb 1
A case of severe hidradenitis suppurativa contributing to a death and a review of the literature.
Elisabeth M. Groginsky, John K. Olson, Thomas A. Lallas, Thomas E. Buekers, Scot A. Potts, Joel I. Sorosky> ;Journal of Lower Genital Tract Disease. 1999 Jan 1
10 citations
Optimization of PCR and Electrophoresis Conditions Enhances Mutation Analysis of the BRCA1 Gene
Thomas A. Lallas, Richard E. Buller> ;Molecular Genetics and Metabolism. 1998 Jul 1
76 citations
CHEMOTHERAPY IN PREGNANCY
Thomas E. Buekers, Thomas A. Lallas> ;Obstetrics and Gynecology Clinics of North America. 1998 Jun 1
8 citations
Vinblastine, ifosfamide, gallium nitrate, and filgrastim in platinum- and paclitaxel-resistant ovarian cancer: a phase II study.
Robert Dreicer, Thomas A. Lallas, Jacqueline K. Joyce, Barrie Anderson, Joel I. Sorosky, Richard E. Buller> ;American Journal of Clinical Oncology. 1998 Jun 1
18 citations
P53 Expression in Adenomyosis in Endometrial Carcinoma Patients
Metin Taskin, Thomas A. Lallas, Maria Shevchuk, Hugh R.K. Barber> ;Gynecologic Oncology. 1996 Aug 1
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
Buller, R. E., Sood, A. K., Lallas, T., Buekers, T., Skilling, J. S.> ;J Natl Cancer Inst. 1999 Feb 17
38 citations
bcl-2 and p53 in endometrial adenocarcinoma.
Metin Taskin, T. A. Lallas, H. R. K. Barber, M. M. Shevchuk> ;Modern Pathology. 1997 Jul 1
3 citations
Metastatic breast carcinoma presenting as endometrial cancer. A case report.
T. A. Lallas, Metin Taskin, A Calanog, M. M. Shevchuk> ;The Journal of Reproductive Medicine. 1997 Feb 1
Microsatellite instability differences between familial and sporadic ovarian cancers.
Arzimanoglou, I. I., Lallas, T., Osborne, M., Barber, H., Gilbert, F.> ;Carcinogenesis. 1996 Sep
Join now to see all